ADVFN - Advanced Financial Network.
HOME» NASDAQ » I » ILMN Stock Price » ILMN Stock News

Illumina Share News

 Illumina (mm) Stock Price
ILMN Stock Price
 Illumina (mm) Stock Chart
ILMN Stock Chart
 Illumina (mm) Stock News
ILMN Stock News
 Illumina (mm) Company Information
ILMN Company Information
 Illumina (mm) Stock Trades
ILMN Stock Trades

Roche Sees No Reason To Raise Illumina Offer

ZURICH -(Dow Jones)- Swiss pharmaceutical giant Roche Holding AG (ROG.VX) Thursday said it sees "no reason whatsoever" to increase its offer for Illumina Inc. (ILMN) without entering talks with management at the U.S. gene-sequencing company. "Our offer of $51 is a full and fair offer and extremely attractive to Illumina shareholders," said Chief Executive Severin Schwan, on a conference call with analysts. Roche's preference remains for a negotiated deal with Illumina, Schwan said, but his company's approach has so far been rebuffed by Illumina's management, he added. "There is no reason whatsoever to increase our offer unless we get into negotiations. So far this is not the case," Schwan said. He was speaking as Roche, the world's biggest maker of cancer drugs, reported first-quarter sales of 11.03 billion Swiss francs ($12.09 billion), down 1% from a year earlier. -By John Revill, Dow Jones Newswires; +41 43 443 8042; john.revill@dowjones.com

Stock News for Illumina (ILMN)
DateTimeHeadline
02/11/201613:36:33Statement of Ownership (sc 13g)
02/11/201604:00:00Genomics England Enters Bioinformatics Partnership with Illumina
02/10/201610:21:04Amended Statement of Ownership (sc 13g/a)
02/10/201609:11:46Current Report Filing (8-k)
02/10/201606:30:00Illumina Building Long Read Application Partnerships
02/03/201610:17:53Amended Statement of Ownership (sc 13g/a)
02/02/201618:40:00Illumina Posts 32% Decline in Profit
02/02/201616:36:32Current Report Filing (8-k)
02/02/201616:32:00Illumina Reports Financial Results for Fourth Quarter and Fiscal...
02/01/201616:42:40Current Report Filing (8-k)
02/01/201606:30:00Illumina Signs Multiple Biobank Deals
01/28/201618:11:12Statement of Changes in Beneficial Ownership (4)
01/28/201608:31:59Current Report Filing (8-k)
01/28/201606:30:00Illumina Appoints Dr. Frances Arnold to Its Board of Directors
01/21/201618:34:29Statement of Changes in Beneficial Ownership (4)
01/19/201606:30:00Illumina to Announce Fourth Quarter and Fiscal Year 2015 Financial...
01/14/201618:03:35Statement of Changes in Beneficial Ownership (4)
01/14/201612:04:17Current Report Filing (8-k)
01/11/201614:31:00Bio-Rad and Illumina to Co-Develop Comprehensive Solution for...
01/11/201614:29:00Illumina Extends Genomics Portfolio

Illumina and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2015 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad